Journal of Clinical & Experimental Pathology
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 1437
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Mark A. Nelson
Mark A. Nelson
Professor
Department of Pathology
Arizona State University
USA
Biography
Mark A. Nelson is Professor of Pathology in University of Arizona.he completed his BS in Microbiology at Washington State University in 1984.In 1989 received PhD in Pharmacology/Toxicology from Washington State University.Expertise in Cancer Biology and Molecular Cell.His research career has been focused towards the molecular genetic studies on cancer (specifically solid tumors). The long-term goals of his research program are to identify genes involved in the etiology of cancers and to use the information from such studies to develop new and innovative treatments to prevent and cure cancers.
Research Interest
Inflammation and Cancer
• Cancer Etiology
• Cancer Chemoprevention and Treatment Target Identification
• Cancer Health Disparities"
Certificate
Global Speakers in the subject
Global Experts in the subject
Publications
The Implications of the BRCA Gene Patent Rulings for Individualized Medicine
| Mark A. Nelson |
| Editorial: J Clinic Experiment Pathol 2011, 1: e101 |
| DOI: |
